Cargando…

A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells

Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liang, Kuang, Yuqiong, Wang, Zhongcheng, Chen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162480/
https://www.ncbi.nlm.nih.gov/pubmed/34094372
http://dx.doi.org/10.1039/d0sc04481d
_version_ 1783700722115674112
author Liu, Liang
Kuang, Yuqiong
Wang, Zhongcheng
Chen, Yun
author_facet Liu, Liang
Kuang, Yuqiong
Wang, Zhongcheng
Chen, Yun
author_sort Liu, Liang
collection PubMed
description Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development of novel methods for accurate HER2 testing is in great demand. Considering the visualization features of in situ imaging and the quantitative capability of mass spectrometry, integration of the two components into a molecular mapping approach has attracted increasing interest. In this work, we reported an integrated chemical mapping approach using a photocleavable peptide-tagged mass probe for HER2 detection. The probe consists of four functional domains, including the recognition unit of an aptamer to catch HER2, a fluorescent dye moiety (FITC) for fluorescence imaging, a reporter peptide for mass spectrometric quantification, and a photocleavable linker for peptide release. After characterization of this novel probe (e.g., conjugation efficiency, binding affinity and specificity, and photolysis release efficiency), the probe binding and photolysis release conditions were optimized. Then, fluorescence images were collected, and the released reporter peptide after photolysis was quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A limit of quantification (LOQ) of 25 pM was obtained, which very well meets the requirements for clinical laboratory testing. Finally, the developed assay was applied for HER2 testing in four breast cancer cell lines and 42 pairs of human breast primary tumors and adjacent normal tissue samples. Overall, this integrated approach based on a photocleavable peptide-tagged mass probe can provide chemical mapping including both quantitative and visual information of HER2 reliably and consistently, and may pave the way for clinical applications in a more accurate manner.
format Online
Article
Text
id pubmed-8162480
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-81624802021-06-04 A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells Liu, Liang Kuang, Yuqiong Wang, Zhongcheng Chen, Yun Chem Sci Chemistry Human epidermal growth factor receptor 2 (HER2) testing has great value for cancer diagnosis, prognosis and treatment selection. However, the clinical utility of HER2 is frequently tempered by the uncertainty regarding the accuracy of the methods currently available to assess HER2. The development of novel methods for accurate HER2 testing is in great demand. Considering the visualization features of in situ imaging and the quantitative capability of mass spectrometry, integration of the two components into a molecular mapping approach has attracted increasing interest. In this work, we reported an integrated chemical mapping approach using a photocleavable peptide-tagged mass probe for HER2 detection. The probe consists of four functional domains, including the recognition unit of an aptamer to catch HER2, a fluorescent dye moiety (FITC) for fluorescence imaging, a reporter peptide for mass spectrometric quantification, and a photocleavable linker for peptide release. After characterization of this novel probe (e.g., conjugation efficiency, binding affinity and specificity, and photolysis release efficiency), the probe binding and photolysis release conditions were optimized. Then, fluorescence images were collected, and the released reporter peptide after photolysis was quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A limit of quantification (LOQ) of 25 pM was obtained, which very well meets the requirements for clinical laboratory testing. Finally, the developed assay was applied for HER2 testing in four breast cancer cell lines and 42 pairs of human breast primary tumors and adjacent normal tissue samples. Overall, this integrated approach based on a photocleavable peptide-tagged mass probe can provide chemical mapping including both quantitative and visual information of HER2 reliably and consistently, and may pave the way for clinical applications in a more accurate manner. The Royal Society of Chemistry 2020-09-30 /pmc/articles/PMC8162480/ /pubmed/34094372 http://dx.doi.org/10.1039/d0sc04481d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Liu, Liang
Kuang, Yuqiong
Wang, Zhongcheng
Chen, Yun
A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title_full A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title_fullStr A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title_full_unstemmed A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title_short A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells
title_sort photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (her2) in human cancer cells
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162480/
https://www.ncbi.nlm.nih.gov/pubmed/34094372
http://dx.doi.org/10.1039/d0sc04481d
work_keys_str_mv AT liuliang aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT kuangyuqiong aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT wangzhongcheng aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT chenyun aphotocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT liuliang photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT kuangyuqiong photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT wangzhongcheng photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells
AT chenyun photocleavablepeptidetaggedmassprobeforchemicalmappingofepidermalgrowthfactorreceptor2her2inhumancancercells